Drug intelligence / Profile preview

Pluviton

Development stage
Unknown
Lead developer
Carl Zeiss Meditec
Modality
Small Molecules
Administration
Oral
01

Overview

Pluviton is a multivitamin supplement developed and marketed by Meditec (MMeditech), an Israeli pharmaceutical company. It is primarily available as an oral solution, such as drops or syrup, and is indicated for the prevention and treatment of vitamin deficiencies, particularly in infants and children. The formulation typically includes a combination of essential micronutrients, including fat-soluble vitamins (Vitamin A and Vitamin D) and water-soluble vitamins (Vitamin C and B-complex vitamins like B1, B2, B3, and B6). These components support critical biological functions such as bone mineralization, immune system maintenance, and cellular energy metabolism. As a marketed consumer health product, it is used for nutritional support rather than as a prescription pharmaceutical for a specific disease pathology.

Brand names
Pluviton
Other names
Pluviton DropsPluviton Syrup
02

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Pluviton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pluviton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call